Validating Epigenetic and Genetic Biomarkers for Diagnosis of Bladder Pain of Interstitial Cystitis
Abstract
The goal of this study is to determine the biosignature consisting of DNA methylation and gene expression status detected in urine from interstitial cystitis/painful bladder syndrome (IC) patients will stratify IC patients from healthy controls. In this funding year, we have focused on (1) identification on baseline of urine collection, (2) expansion of database for better urine biomarker discovery, and (3) technology application to further identify the DNA methylation markers associated with IC. In particular, we were able to optimize the DNA methylation and gene expression assays, which were designed for high throughput screening (HTS).
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2020
- Accession Number
- AD1100286
Entities
People
- Jayoung Kim
Organizations
- Cedars-Sinai Medical Center